Notch inhibitors for cancer treatment-Reference-Cited by-同舟云学术

Notch inhibitors for cancer treatment

Published:2013-08 Issue:2 Volume:139 Page:95-110
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Espinoza Ingrid,Miele Lucio

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference261 articles.

1. Rumi is a CAP10 domain glycosyltransferase that modifies Notch and is required for Notch signaling;Acar;Cell,2008

2. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1;Agrawal;Science,2011

3. Recruitment of IkappaBalpha to the hes1 promoter is associated with transcriptional repression;Aguilera;Proc Natl Acad Sci U S A,2004

4. Modulation of cancer stem cell biomarkers by the Notch inhibitor MK0752 added to endocrine therapy for early stage ER+breast cancer;Albain;Cancer Res,2011

5. Activated Notch1 induces lung adenomas in mice and cooperates with Myc in the generation of lung adenocarcinoma;Allen;Cancer Res,2011

Cited by 242 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Notch signaling pathways with natural bioactive compounds: a promising approach against cancer;Frontiers in Pharmacology;2024-07-18

2. Seedless black Vitis vinifera polyphenols suppress hepatocellular carcinoma in vitro and in vivo by targeting apoptosis, cancer stem cells, and proliferation;Biomedicine & Pharmacotherapy;2024-06

3. Cell surface markers and signaling pathways of cancer stem cells: target for potent therapeutics;Cancer Stem Cells and Signaling Pathways;2024

4. LINC00460 promotes neuroblastoma tumorigenesis and cisplatin resistance by targeting miR-149-5p/DLL1 axis and activating Notch pathway in vitro and in vivo;Drug Delivery and Translational Research;2023-12-31

5. Shrinking the battlefield in cancer therapy: Nanotechnology against cancer stem cells;European Journal of Pharmaceutical Sciences;2023-12